Olivier is an accomplished antibody engineer with more than 30-year experience having worked for biotech (MRC collaborative centre and NovImmune) and pharma companies (Pierre Fabre, Merck Serono and Vetoquinol). Co-inventor of three marketed therapeutic antibodies, Tysarbri, Bavencio and Gamifant. Co-founder of the technology company Deeptope. Olivier has expertise in antibody
Jean-François has been working in the field of immunology for 25-yr + including 18 years for several biotech and pharmaceutical companies (Serono Pharmaceutical, Merck Serono SA, Merck KGaA, Fresenius-Kabi, and GeNeuro SA). He has expertise in the development of biologics for FiM readiness including selection of PoC studies to serve autoimmune,
Régis brings more than 25 years of experience in the areas of finance, structuring and management of health technology companies. Prior to joining Tridek-One, Régis was CEO of Axess Vision Technology, a company dedicated to the development of single-use medical endoscopes, where he led the launch of new products and
Laurence is a seasoned pharma/biotech professional with over 25 years of experience in transactions and R&D operations and general management. She has worked in VC funded biotech start-ups, mid-size private companies as well as large corporate organizations. Prior to joining Tridek-One, Laurence was COO and CBO of AMAL Therapeutics, a